John Michael Dunn - Net Worth and Insider Trading
John Michael Dunn Net Worth
The estimated net worth of John Michael Dunn is at least $3 Million dollars as of 2024-11-09. John Michael Dunn is the EVP, New Ventures of Biogen Inc and owns about 18,712 shares of Biogen Inc (BIIB) stock worth over $3 Million. John Michael Dunn is the Director of Acer Therapeutics Inc and owns about 27,380 shares of Acer Therapeutics Inc (ACER) stock worth over $18,074. John Michael Dunn is also the General Counsel and Secretary of Immunic Inc and owns about 297 shares of Immunic Inc (IMUX) stock worth over $353. Details can be seen in John Michael Dunn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Michael Dunn has not made any transactions after 2020-07-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Michael Dunn
John Michael Dunn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Michael Dunn owns 3 companies in total, including Acer Therapeutics Inc (ACER) , Immunic Inc (IMUX) , and Biogen Inc (BIIB) .
Click here to see the complete history of John Michael Dunn’s form 4 insider trades.
Insider Ownership Summary of John Michael Dunn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACER | Acer Therapeutics Inc | 2020-07-24 | director |
| IMUX | Immunic Inc | 2017-06-14 | General Counsel |
| BIIB | Biogen Inc | 2009-02-19 | EVP & New Ventures |
John Michael Dunn Latest Holdings Summary
John Michael Dunn currently owns a total of 3 stocks. Among these stocks, John Michael Dunn owns 18,712 shares of Biogen Inc (BIIB) as of February 19, 2009, with a value of $3 Million and a weighting of 99.43%. John Michael Dunn owns 27,380 shares of Acer Therapeutics Inc (ACER) as of July 24, 2020, with a value of $18,074 and a weighting of 0.56%. John Michael Dunn also owns 297 shares of Immunic Inc (IMUX) as of June 14, 2017, with a value of $353 and a weighting of 0.01%.
Latest Holdings of John Michael Dunn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BIIB | Biogen Inc | 2009-02-19 | 18,712 | 173.02 | 3,237,550 |
| ACER | Acer Therapeutics Inc | 2020-07-24 | 27,380 | 0.66 | 18,074 |
| IMUX | Immunic Inc | 2017-06-14 | 297 | 1.19 | 353 |
Holding Weightings of John Michael Dunn
John Michael Dunn Form 4 Trading Tracker
According to the SEC Form 4 filings, John Michael Dunn has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 3,208 shares on February 19, 2009, which brought John Michael Dunn around $163,287.
According to the SEC Form 4 filings, John Michael Dunn has made a total of 1 transactions in Acer Therapeutics Inc (ACER) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acer Therapeutics Inc is the acquisition of 21,428 shares on July 24, 2020, which cost John Michael Dunn around $74,998.
According to the SEC Form 4 filings, John Michael Dunn has made a total of 0 transactions in Immunic Inc (IMUX) over the past 5 years. The most-recent trade in Immunic Inc is the acquisition of 63 shares on June 14, 2017, which cost John Michael Dunn around $7,725.
Insider Trading History of John Michael Dunn
- 1
John Michael Dunn Trading Performance
GuruFocus tracks the stock performance after each of John Michael Dunn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Michael Dunn is 14.21%. GuruFocus also compares John Michael Dunn's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Michael Dunn within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Michael Dunn's insider trading performs compared to the benchmark.
Performance of John Michael Dunn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.85 | | | | | |
| Relative Return to S&P 500(%) | 0.04 | | | | | |
John Michael Dunn Ownership Network
Ownership Network List of John Michael Dunn
Ownership Network Relation of John Michael Dunn
John Michael Dunn Owned Company Details
What does Acer Therapeutics Inc do?
Who are the key executives at Acer Therapeutics Inc?
John Michael Dunn is the director of Acer Therapeutics Inc. Other key executives at Acer Therapeutics Inc include director & President and Chief Executive Chris Schelling , Chief Operating Officer Tanya Hayden , and Chief Medical Officer Adrian W Quartel .
Acer Therapeutics Inc (ACER) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acer Therapeutics Inc (ACER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acer Therapeutics Inc (ACER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acer Therapeutics Inc (ACER)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acer Therapeutics Inc Insider Transactions
John Michael Dunn Mailing Address
Above is the net worth, insider trading, and ownership report for John Michael Dunn. You might contact John Michael Dunn via mailing address: C/o Vital Therapies, Inc., 15010 Avenue Of Science, Suite 200, San Diego Ca 92128.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
